Improved hand hygiene is known to reduce transmission of both respiratory (RTI) and gastrointestinal infections (GTI) under "semi-closed" conditions such as hospitals, day-care centres and schools. It is not known if similar interventions would have the desired effect in a regular office work. This study is aiming to investigate this possibility by recruiting volunteers from several companies in the Helsinki Region. The two intervention groups will receive detailed instructions e.g. for proper coughing and sneezing, and for regular cleaning of hands with either standard liquid soap or with alcohol-based gel rubbing. Third group will serve as the control and is advised not to change their previous behaviour in this respect. The participants will report weekly possible RTI or GTI symptoms and related days off through internet. The study is planned to run about 18 months to cover the seasonal variation of the epidemics of the causative different viruses.

Start Date01 Jan 2009

Sponsor / Collaborator

National Institute For Health & Welfare

[+4]

100 Clinical Results associated with Outokumpu Srl

0 Patents (Medical) associated with Outokumpu Srl

Literatures (Medical) associated with Outokumpu Srl

01 Mar 2016·Materials Science and Engineering: A

Effects of reversion and recrystallization on microstructure and mechanical properties of Nb-alloyed low-Ni high-Mn austenitic stainless steels

Author: J. Talonen ; L.P. Karjalainen ; A.S. Hamada ; A. Kisko ; D. Porter

The influence of reversion annealing on the microstructure and mech. properties of an austenitic high-Mn low-Ni 15Cr-9Mn-1.1Ni-1.7Cu stainless steel with and without Nb alloying was investigated.The steel sheets were cold rolled to a 60% thickness reduction to obtain ∼60% of strain-induced α'-martensite and subsequently annealed at temperatures between 700 and 1100° for 0.1-1000 s to revert the α'-martensite back to austenite and recrystallize the retained austenite.Microstructure evolution was studied using x-ray diffraction, magnetic measurements, optical microscopy and electron backscatter diffraction techniques.Mech. properties were determined using microhardness measurements and tensile tests at room temperatureReversion could be completed at 700° but then recrystallization of the retained austenite remained partial.At 800°, a non-uniform grain structure was obtained consisting of ultrafine-grained areas formed via α'-martensite reversion and coarser ones by recrystallization of the retained austenite, whereas at 900° a uniform austenite grain size in the range of 1-2 μm was obtained for all the steels.The non-uniform grain structures exhibited excellent combinations of strength and ductility.The major contribution to the strength is attributed to the refined grain size.The strain hardening rate was higher for the Nb-free steel, even though strain-induced α'-martensite fractions after fracture were slightly lower than in the Nb-alloyed steels.

01 Apr 2015·Safety Science

Health and safety management in a changing organisation: Case study global steel company

Author: Seppo Väyrynen ; Philip Rodrigo ; Maarit Koivupalo ; Marko Sulasalmi

When an organisation changes, grows, or new units join into a corporation, it generates challenges for health and safety (HS) management. There are different types of HS tools, systems, applications, forms and software which support HS management. The purpose of this research is to find out what kind of HS management practices and tools are used and what is required to manage HS efficiently within a global steel company's (Nemployees = 15.000) different sites. All the sites (N = 6) had a health and safety management system, which was based on OHSAS 18001 requirements. Local HS management practices and tools varied significantly, but had similar backgrounds. Corporate HS management was based around HS standards, vision and principles, plans and targets. Similarly, it also followed OHSAS requirements. Some improvement needs have been identified for both the local and the corporate level HS management practices and tools. It is possible to manage HS in a continuously changing organisation. The foundations should be based on corporate HS standards, which should be outlined clearly - based on the desired end result complying with the external requirements.

01 Jan 2015·Integrated Occupational Safety and Health Management

Integrated Management Within a Finnish Industrial Network: Steel Mill Case of HSEQ Assessment Procedure

Author: Heidi Junno ; Seppo Väyrynen ; Maarit Koivupalo

This chapter describes supplier’s HSEQ management practices in general industrial context and in a shared workplace at a case company’s premises. The case company is steel mill in Northern Finland. In addition, three supplying companies which operated in this shared workplace were selected to be a subject of research. HSEQ AP is a supplier’s management procedure used by seven principal companies in Finland. The aim is to describe HSEQ AP in details, and the current situation of different supplier’s HSEQ assessment practices in the case company. There were many different methods used for supplying companies’ HSEQ management, and the principal company selected the main methods to be used: HSEQ AP and after-work HSEQ evaluation, in addition to safety requirements for service supplier form. Supplying companies’ experiences of HSEQ AP were encouraging, but further development for HSEQ AP is needed. Safety indicators and the results of HSEQ AP were studied. Safety performance has improved in both the principal and supplying companies, but at the same time there have been many other safety activities in progress. Thus, it is not clear how much HSEQ AP has affected at the end to this positive development. Moreover, research for additional safety indicators is needed to prove more specifically the actual safety performance level, especially for supplying companies.

News (Medical) associated with Outokumpu Srl

21 Dec 2023

·www.coatingsworld.com

Tamara Weinert Proposed for Supervisory Board of BASF SE

The Supervisory Board of BASF SE has nominated Tamara Weinert, president and CEO of Business Area Americas of Outokumpu, based in the United States, for election as shareholder representative on the Supervisory Board. The election is to take place at the Annual Shareholders’ Meeting of BASF SE on April 25, 2024. Weinert is to succeed Dame Alison Carnwath, who will not stand for election to BASF’s Supervisory Board next year. Carnwath has been a member of BASF’s Supervisory Board since May 2014. She would therefore no longer considered to be independent according to the criteria of the German Corporate Governance Codex in the course of her mandate if she were to be re-elected for four years. “With Tamara Weinert, we have been able to find an experienced and competent leader as a candidate for election to the Supervisory Board of BASF SE. She will strengthen the diversity and independence of the Board,” said Dr. Kurt Bock, chairman of the Supervisory Board of BASF SE. Weinert began her professional career at Deutsche Bank, where she held various positions in Europe and Asia. Since 2021, Weinert is resident and CEO of Business Area Americas and member of the leadership team of Outokumpu. The company is a leading global supplier of sustainable stainless steel.

Executive Change

13 May 2019

·www.globenewswire.com

Outokumpu – Manager transaction: Kari Jordan

Outokumpu Oyj Stock exchange release Manager transaction May 13, 2019 at 4.45 pm EEST Outokumpu – Manager transaction: Kari Jordan Outokumpu has received a notification of a receipt of shares from Kari Jordan, member of the Board of Directors, according to the EU Market Abuse Regulation. According to the decision taken at the Annual General Meeting, 40% of the annual remuneration of the members of the Board of Directors will be paid in the Company’s own shares. Detailed information is given in the table below. Name of the manager Kari Jordan Position in the issuer Member of the Board of Directors Issuer Outokumpu Oyj Issuer’s LEI reference 5493009YRUJJDCFF0R80 Notification type Initial notification Date of the transaction May 9, 2019 Venue Outside a trading venue Nature of transaction Receipt of a share-based incentive or remuneration Instrument Outokumpu share (OUT1V, ISIN: FI0009002422) Transaction details Volume: 21,087 Price: 0.00 (EUR) Aggregated transactions Volume: 21,087 Average price: 0.00 (EUR) Total ownership of the instrument after the transaction 102,474 shares For more information: Corporate communications, tel. +358 9 421 3840 Outokumpu Oyj Outokumpu is the global leader in stainless steel. We aim to be the best value creator in stainless steel by 2020, through our competitive edge of customer orientation and efficiency. The foundation of our business is our ability to tailor stainless steel into any form and for almost any purpose. Stainless steel is sustainable, durable and designed to last forever. Our customers use it to create civilization’s basic structures and its most famous landmarks as well as products for households and various industries. Outokumpu employs 10,000 professionals in more than 30 countries, with headquarters in Helsinki, Finland and shares listed in Nasdaq Helsinki. www.outokumpu.com

100 Deals associated with Outokumpu Srl

100 Translational Medicine associated with Outokumpu Srl

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 20 Jun 2025

No data posted

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis

Outokumpu Srl

Overview

Related

Corporation Tree

Pipeline

Pipeline Snapshot as of 20 Jun 2025

Deal

Translational Medicine

Profit

Grant & Funding(NIH)

Investment

Financing